Rory Balfour Riggs
Independent Director, StageZero Life Sciences Ltd.
Founder of 12 different companies, notably: Royalty Pharma Plc, Cibus, Inc. and FibroGen, Inc. Rory Balfour Riggs is an entrepreneur and businessperson who has been at the head of 15 different companies and is Chairman & CEO (Co-founder) at Cibus Corp. (which he founded in 2001), Chairman of Cibus Ltd. and Chairman for Nucelis, Inc. (both are subsidiaries of Cibus Corp.), Chairman & Chief Executive Officer at Cibus, Inc. (which he founded), Executive Chairman (Founder) at Syntax LLC (since 2009), Chief Executive Officer & Trustee at Syntax ETF Trust, CEO (Founder) at Locus Analytics LLC (which he founded in 2010) and Chief Executive Officer at Syntax Advisors LLC (which he founded) (which are all subsidiaries of Syntax LLC), Chief Executive Officer at Syntax Analytics LLC (which he founded in 2010) and General Partner for Scientia Ventures LLC (which he founded in 2006). He is also Managing Member at Balfour Venture Partners and on the board of 5 other companies.
Mr. Riggs previously occupied the position of Managing Member at Balfour LLC, Director at eReceivables Inc. (he founded the company in 2003), President & Chief Executive Officer of The RF&P Corp., Associate at Strategic Planning Associates, President, Chief Financial Officer & Director at Biomatrix, Inc., Managing Member at New Ventures I LLC, Managing Director at PaineWebber, Inc., Principal at Pacific Media Partners, Inc., Chairman/Director at Sugen, Inc. and Board Member (Co-founder) at FibroGen, Inc.
Mr. Riggs received an undergraduate degree from Middlebury College and an MBA from The Trustees of Columbia University in The City of New York.